Trading Summary - October 6. Another satisfactory

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
233
Trading Summary - October 6.

Another satisfactory consolidation day for $DIGX in the pre-Q3 holding pattern. Again the whale longs preventing anyone getting a significant amount of .0003s whilst allowing others the opportunity to load at .0005 on the ask and / or bid .0004 before they take them out at a time of their choosing before the Q3 filing.

There were several changing significant manipulation attempts using a stacked ask and bashing on iHub (see contemporaneous record for a possible report to SEC in earlier posts here).

There were no significant bid pick ups at .0004 or .0003 - personally I bought 1.999800 at .0003 on the bid at .0003 (from August 14) and 1M at .0004 on the ask.

14.4M was loaded today - 10.8M at .0004 and 3.6M at .0003.

When it showed briefly, the .0003 visible bid was 153M.

It is still clear that the prospect of getting any significant amount of .0004s is extremely slim - just insignificant amounts from whatever small paint downs are made before those that want to add before the pre-load Q3 run take out the remaining .0005s. There has always been almost zero chance of getting any meaningful amount of .0003s and certainly none now before the next run.

Only 27 trading days remain now to the filing of the Q3 Report (due November 15) - with demand-led pre-runs usually happening 4-6 weeks prior based on pre-Q1 and pre-Q2 experience so stay sharp if you don't already have all the shares you need to make your profit expectations.

In my experience, 70M>100M is the optimum amount to take best advantage of each run whilst keeping the 25M cheapest batches for the bigger runs next year (especially Q4 in March 2018 when the full year profits will be up). My cheapest 25M retained for next year will not require any shares bought above .0004 now so all others will be tradeable for up to 100% during the remaining runs in 2017.

Watch closely over next week if you can to see if a few of the at least 4 whales known to be in $DIGX decide to take out the .0005s.

Content below line mainly unchanged from last update - relevant to those that are new here.

There are at least 4 x whales who trade $DIGX continuously throughout each year who will be happy to take around 20M each if anyone is stupid or impatient enough to sell for a loss at any level below the current one. Any shares bought at .0004 will be worth an easy 150%+ profit on any of numerous runs likely to happen through to Q3 and Q4.

Expect the status quo to be maintained until the next pre-Q3 run, with it making little difference to long-term traders whether shares are picked up at .0004/5/6 - they will see a profit on all of them by Q3 / Q4 and on various runs between. the big boys in DIGX will probably be aiming to have an inventory of 50M>120M (based on near instantaneous loading seen across 2 price points in seconds when coming off the inter-Q bottom before).

Also expect an element of the .0003 bidders - particularly those unlikely to fill on paint downs in the time remaining before the next run prior to Q3 at latest - to continue to buy .0004s and .0005s whilst they are still available. Only 20% of the bid at .0003 hitting the ask at .0005 would be sufficient to take out even the current fake ask if left there.

We can now look forward to additional updates on both the possible merger discussed recently and the implementation of the additional services being offered in the chiropractic chain offices - per the Strategic Growth Plan just announced - over the coming days, weeks and months..

The long whales will continue to buy at all prices that makes sense to them at any given point to have a cache for trading on any demand led run, the Q3 and through to the Annual Report in March 2018.

$DIGX will most likely not be allowed to go to previous year-end or inter-Q lows.

In my opinion, nobody has bought $DIGX in 2017 at a price that it isn't likely to exceed in the coming months (2017 high .0013) through to the Annual Report (March 2018).

Ludicrous claims by the notorious bashers currently on iHub - "RFB", "munimi", "Crown Capital" and "surfkast" - are clearly seen as such by all serious traders and now even by most short term (next Q) iHubbers.

Debunking nonsense posted by morons on iHub, there is absolutely no need or intention to do a reverse split. The share structure is exceptionally thin - with no dilution - and the company has been buying back shares. OTC market specialists who trade $DIGX continuously would not be loading 50M>100M shares at these inter-Q bottom prices to trade over the next 6 months if there was even the remote possibility of a reverse split.

Regardless of whether iHub posters lose interest over the coming days and weeks, detailed coverage will continue here as $DIGX remains one of my top picks for repeat profits for those that are patient and trade it to best effect (keep all cheapest batches of shares - create an inventory of shares at higher prices to trade on every run - big or small).

In addition, money is not considered "dead" by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.






American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 201

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 192

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 249

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 298

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 193

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 158

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 190

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding State Resilience Against Future Economic Challenges

Updated Category News Views 119

States Vulnerable to Economic Downturns The landscape of economic stability is shifting, and many residents might be unaware of how their home states rank in terms of recession preparedness. Recent analyses reveal striking differences in resilience that could significantly impact everyday Americans. With numerous warnings about incoming economic turbulence, it’s crucial...

Continue Reading
Liquidia's Milestone Funding for YUTREPIA™ Sales Surge

Updated Category News Views 334

Liquidia Corporation Announces Significant Funding Boost Liquidia Corporation (NASDAQ: LQDA), a prominent biopharmaceutical company, is thrilled to announce that it has secured an additional $50 million to support the launch of its innovative treatment, YUTREPIA™. This exciting development follows a pivotal legal victory where a U.S. District Court ruled against a...

Continue Reading
Paratus Energy Services Ltd. Reports Mandatory Trade Update

Updated Category News Views 189

Paratus Energy Services Ltd. Reports Mandatory Trade Notification Paratus Energy Services Ltd. has recently announced a significant trade notification involving a close associate of one of its board members. The company, which operates in the energy sector, has revealed that a fund managed by Lodbrok Capital LLP has completed a trade involving its shares. This information...

Continue Reading
Angel Launches Global Theatrical Release of David Musical

Updated Category News Views 181

Angel's Global Release of David Musical Animated musical builds powerful momentum as early domestic pre-sales surge close to $6 million Angel (NYSE: ANGX), a leading media and technology company championing values-driven stories, is setting the stage for the theatrical release of the eagerly awaited animated musical David across 43 international markets. This significant...

Continue Reading
LifeMD, Inc. Announces Exciting Dividend for Shareholders

Updated Category News Views 116

LifeMD, Inc. Announces Quarterly Dividend LifeMD, Inc. (NASDAQ: LFMD), recognized for its pioneering virtual primary care offerings, has announced an important cash dividend for its shareholders. The Company's Board of Directors has declared a cash dividend of $0.5546875 per share on the 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP). This...

Continue Reading